We are live on ! Find out more
BJCM

Blue Jay Capital Management Portfolio holdings

AUM $147M
1-Year Est. Return 64.18%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+64.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$297M
AUM Growth
+$42M
Cap. Flow
+$28.5M
Cap. Flow %
9.59%
Top 10 Hldgs %
53.44%
Holding
31
New
13
Increased
3
Reduced
7
Closed
8

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$19.1M
2
ENDP
Endo International plc
ENDP
+$15.5M
3
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$13.4M
4
HOLX
Hologic
HOLX
+$12.7M
5
IPXL
Impax Laboratories, Inc.
IPXL
+$11.8M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$16M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14.7M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$14.1M
4
NUVA
NuVasive, Inc.
NUVA
+$13.7M
5
WCG
Wellcare Health Plans, Inc.
WCG
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 82.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
26
Centene
CNC
$30.5B
– –
-473,008
Closed -$12.8M
INCY icon
27
Incyte
INCY
$25.8B
– –
-144,710
Closed -$16M
NKTR icon
28
Nektar Therapeutics
NKTR
$2.39B
– –
-73,333
Closed -$12.1M
NUVA
29
DELISTED
NuVasive, Inc.
NUVA
– –
-285,000
Closed -$13.7M
ALXN
30
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-89,884
Closed -$14.1M
WCG
31
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-150,000
Closed -$12.9M
1
2

Similar funds

BCM
Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return
RJA
Robshaw & Julian Associates Williamsville, New York $140M AUM 13.69% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return
ACPVT
ABS Capital Partners V Trust Baltimore, Maryland $123M AUM
SFA
Staton Financial Advisors Charlotte, North Carolina $118M AUM 11.07% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
KFS
Kissinger Financial Services Hunt Valley, Maryland $100M AUM 6.22% 1-Year Est. Return
FHC
First Houston Capital Houston, Texas $100M AUM 23.45% 1-Year Est. Return

Blue Jay Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Blue Jay Capital Management held 31 positions worth $297M, up 17% from $255M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Blue Jay Capital Management deployed $28.5M of net new capital in Q4 2015, opening 13 new positions and adding to 3 existing holdings. Its largest new stake was Shire pic: 92,030 shares worth $18.9M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 86% a quarter earlier.

On the sell side, the largest reduction was Perrigo, an estimated $7.6M trimmed.

  • Blue Jay Capital Management's largest Q4 2015 buy was Shire pic: 92,030 shares worth $18.9M.
  • Blue Jay Capital Management added most to Biogen in Q4 2015, an estimated $4.5M increase.
  • Blue Jay Capital Management's biggest Q4 2015 reduction was Perrigo, cutting an estimated $7.6M.
  • Blue Jay Capital Management fully exited Incyte in Q4 2015, selling an estimated $16M.
  • Blue Jay Capital Management's ten largest holdings make up 53% of its $297M portfolio in Q4 2015.
  • Blue Jay Capital Management opened 13 new positions and closed 8 in Q4 2015.
  • Blue Jay Capital Management's portfolio value rose 17% quarter-over-quarter to $297M.

Based on Blue Jay Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.